COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Elegen develops cell-free microfluidics DNA synthesis and production platforms (ENFINIA DNA), offering rapid, longer/complex sequence synthesis, turnkey GMP-compliant and IVT-/plasmid-ready DNA for research and clinical workflows, partnered with GSK.
